They demonstrated again that TIM3 expression on the surface of primitive cells and plasma levels of the TIM3 ligand, galactoselectin-9 (Gal-9), are dynamically elevated with the transformation of MDS to AML and are closely associated with primitive cell proliferation, disease progression, and prognosis (27). Here, LGALS9 is linked to myelodysplastic syndrome.